Grupp S, Maude S, Baruchel A, et al. Tisagenlecleucel appears effective and safe in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia with high-risk cytogenetic abnormalities. 24th Congress of EHA, abstract S1618.
Involved-fieldradiotherapie voorkomt recidief bij vroeg stadium PET-negatief HL na ABVD
dec 2021 | Lymfoom, Radiotherapie